Evidence map›Paper›PMID 38721518›Full record

ArticleInternational journal of ophthalmology2024

Treatment of uveitis and scleritis patients in Malaysia.

Sieng Teng Seow, Iqbal Tajunisah, Fei Yee Lee, Pooi Wah Lott, Sagili Chandrasekhara Reddy

Abstract read
In one paragraph

Article in International journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sieng Teng SeowDepartment of Ophthalmology, University Malaya Eye Research Centre (UMERC), Faculty of Medicine, Universiti Malaya, Kuala Lumpur 59100, Malaysia.
Iqbal TajunisahDepartment of Ophthalmology, University Malaya Eye Research Centre (UMERC), Faculty of Medicine, Universiti Malaya, Kuala Lumpur 59100, Malaysia.
Fei Yee LeeClinical Research Centre, Selayang Hospital, Ministry of Health Malaysia, Selangor 68100, Malaysia.
Pooi Wah LottDepartment of Ophthalmology, University Malaya Eye Research Centre (UMERC), Faculty of Medicine, Universiti Malaya, Kuala Lumpur 59100, Malaysia.
Sagili Chandrasekhara ReddyDepartment of Ophthalmology, Faculty of Medicine and Defence Health, National Defence University of Malaysia, Kuala Lumpur 57000, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine the common causes and visual outcome after treatment among uveitis and scleritis patients.

methodsThis is a retrospective cohort observational study. All consecutive clinical records of patients with newly diagnosed uveitis and scleritis over a 4-year period, from Jan. 1, 2017 to Dec. 31, 2020, were analysed. Data was collected at the presentation and included a follow-up period of one year.

resultsA total of 288 patients were recruited during the study period. Anterior uveitis was the most common anatomical diagnosis (50.0%) followed by panuveitis (25.0%), scleritis (13.5%), posterior uveitis (6.9%), and intermediate uveitis (4.5%). Viral Herpes was the most common cause of infectious cases, while Vogt-Koyanagi-Harada (VKH) disease and human leucocyte antigen (HLA) B27 spondyloarthropathy were the leading causes of identifiable non-infectious cases. Majority of patients presented with unilateral, non-granulomatous uveitis with an absence of hypopyon. Anatomical locations like posterior uveitis and panuveitis, and visual acuity worse than 3/60 at presentation were the factors associated with poor visual outcomes (

conclusionUveitis and scleritis are important causes of ocular morbidity. They are potentially blinding diseases which can have a good outcome if diagnosed and treated early.

Indexed as

aetiologyblindnessocular morbidityscleritisuveitis

Identifiers

PMID38721518
PMCPMC11074168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.